Combined Spinal Epidural Urinary Retention
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01597791|
Recruitment Status : Terminated (Change in procedure.US technically challenging.)
First Posted : May 14, 2012
Results First Posted : October 10, 2017
Last Update Posted : October 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|Anesthesia Pain Urinary Retention||Device: Foley catheter Other: No foley catheter||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||56 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Do Women Receiving Low Dose Combined Spinal Epidural for Labor Analgesia Exhibit Less Bacteriuria Using a Urinary Retention Protocol Versus Routine Urinary Catheter Placement?|
|Actual Study Start Date :||March 22, 2012|
|Actual Primary Completion Date :||December 1, 2016|
|Actual Study Completion Date :||December 1, 2016|
Placebo Comparator: Foley catheter
Control group will have a Foley catheter placed after the CSE is performed as is the usual practice at this institution.
Device: Foley catheter
Foley catheter placement after CSE.
Experimental: No Foley Catheter
Spontaneous micturition algorithm will be assessed for spontaneous micturition and post void residual (PVR) volumes via ultrasonography at regular time intervals.
Other: No foley catheter
Spontaneous Micturation/ Post Void Residual. the spontaneous micturition algorithm will be assessed for spontaneous micturition and post void residual (PVR) volumes via ultrasonography at regular time intervals.
- Number of Participants With Positive Urine Culture [ Time Frame: 48 Hours ]This study will be assessed by collecting a twenty-four to forty-eight hour midstream urine sample and performing a urine culture. The clinical and laboratory criteria used to define a urinary tract infection.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01597791
|United States, Illinois|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Jeanette Bauchat, M.D.||Northwestern University|